未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Toxicity in the era of immune checkpoint inhibitor therapy Keam, Synat; Turner, Naimah; Kugeratski, Fernanda G.; Rico, Rene; Colunga-Minutti, Jocelynn; Poojary, Rayansh; Alekseev, Sayan; Patel, Anisha B.; Li, Yuanteng Jeff; Sheshadri, Ajay; Loghin, Monica E.; Woodman, Karin; Aaroe, Ashley E.; Hamidi, Sarah; Iyer, Priyanka Chandrasekhar; Palaskas, Nicolas L.; Wang, Yinghong; Nurieva, Roza 分享 收藏
Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events Fayle, Sarah E.; Palaskas, Nicolas L.; Siddiqui, Bilal A.; McQuade, Jennifer L.; Lin, Jamie S.; Subudhi, Sumit K.; Patel, Anisha B.; Jenq, Robert R.; Shah, Amishi Y.; Spelman, Amy R.; Sun, Mianen; Marble, Bettina H.; Wang, Yinghong 分享 收藏
Phase II Trial of Combination of Atezolizumab, Cobimetinib and Eribulin (ACE) or Atezolizumab and Eribulin (AE) in patients with metastatic inflammatory breast cancer (IBC): Clinical data of both cohorts Alexander, Angela; Murphy, Hope; Reuben, James; Le-Petross, H. T. Carisa; Lane, Deanna; Huang, Monica; Krishnamurthy, Savitri; Gong, Yun; Gombos, Dan; Patel, Nimisha; Allen, Richard; Liu, Suyu; Patel, Anisha; Futreal, Andrew; Wistuba, Ignacio; Layman, Rachel; Ueno, Naoto; Tripathy, Debu; Lim, Bora; Valero, Vicente 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Biomarker analysis: Multi-omics elucidation of Cohort 1 from a phase II study of a triple combination of Atezolizumab plus cobimetinib plus eribulin in patients with metastatic inflammatory breast cancer Lim, Bora; Alexander, Angela; Willey, Jie S.; Sun, Huiming; Liu, Suyu; Patel, Anisha B.; Parra, Edwin Roger; Haymaker, Cara; Soto, Luisa Solis; Serrano, Alejandra; Sun, Baohua; Lima, Cibelle Freitas Pinto; Tamegnon, Auriole; Pandurengan, Renganayaki K.; Douse, Dzifa; Lan, Jessica; Raja, Luthra; Chu, Randy; Knafl, Mark; Woodman, Scott E.; Zhu, Haifeng; Shulze, Katja; Fedenko, Katherine; Darbonne, Walter; Ueno, Naoto T.; Valero, Vicente 分享 收藏
分享 收藏
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study 检查点抑制剂在血管肉瘤中的临床活性: 一项回顾性队列研究 Ravi, Vinod; Subramaniam, Aparna; Zheng, Jing; Amini, Behrang; Trinh, Van A.; Joseph, Jocelyn; Mennel, Robert G.; Bishop, Andrew J.; Sturgis, Erich M.; Goepfert, Ryan P.; Yalamanchili, Sudha; Botello, Gilberto; Stephen, Bettzy; Piha-Paul, Sarina A.; Patel, Anisha B.; Lazar, Alexander J.; Conley, Anthony P.; Benjamin, Robert S.; Patel, Shreyaskumar R.; Futreal, Phillip A.; Somaiah, Neeta; Naing, Aung 分享 收藏
分享 收藏
Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit Patel, Anisha B.; Farooq, Sahira; Welborn, Macartney; Amaria, Rodabe N.; Chon, Susan Y.; Diab, Adi; Oliva, Isabella C. Glitza; Huen, Auris O.; Li, Shirley Q.; Nelson, Kelly C.; Pacha, Omar; Patel, Sapna P.; Rapini, Ronald P.; Tawbi, Hussein A.; Wong, Michael K.; McQuade, Jennifer; Davies, Michael A.; Haydu, Lauren E. 分享 收藏
Dermatopathological review of cutaneous squamous cell carcinoma events in patients with gastrointestinal stromal tumors treated with ripretinib Patel, A.; George, S.; Janku, F.; Ganjoo, K.; Young, R.; Chi, P.; Westwood, D.; Stearns, S.; Meade, J.; Ruiz-Soto, R.; Lacouture, M. 分享 收藏
IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies Barrios, D. M.; Phillips, G. S.; Geisler, A. N.; Trelles, S. R.; Markova, A.; Noor, S. J.; Quigley, E. A.; Haliasos, H. C.; Moy, A. P.; Schram, A. M.; Bromberg, J.; Funt, S. A.; Voss, M. H.; Drilon, A.; Hellmann, M. D.; Comen, E. A.; Narala, S.; Patel, A. B.; Wetzel, M.; Jung, J. Y.; Leung, D. Y. M.; Lacouture, M. E. 分享 收藏